Alphabet's DeepMind introduces AI model AlphaGenome for DNA research

From Yahoo Finance.: 2025-06-27 07:38:00

Alphabet Inc. (NASDAQ: GOOGL) introduces AlphaGenome, an AI model that predicts genetic variations in human DNA. The tool helps scientists understand how DNA impacts biological processes. It can analyze up to 1 million DNA base pairs and predict molecular properties related to regulatory activity.

AlphaGenome is available for non-commercial research via AlphaGenome API. It will help predict genetic disruptions, design synthetic DNA, and accelerate genome understanding. Professor Marc Mansour from University College London praises the tool’s potential in connecting non-coding variants to diseases like cancer.

Alphabet Inc. (NASDAQ: GOOG) is a multinational technology conglomerate owning Google and other businesses. While GOOG shows investment potential, some AI stocks offer greater upside with less risk. For an undervalued AI stock benefiting from tariffs and onshoring trends, check out the best short-term AI stock in a free report.

Read more: Alphabet Google’s (GOOGL) DeepMind Unveils AlphaGenome to Revolutionize DNA Research